Moleculin Biotech, Inc. ( MBRX) - Key Metrics
MBRX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$1.34 | -$1.17 | -$1.17 |
| 2026Q1 | $0 | -$3.11 | -$1.48 | -$1.48 |
| 2025Q4 | $0 | $4.86 | -$1.68 | -$1.68 |
| 2025Q3 | $0 | -$17.02 | -$4.84 | -$4.84 |
| 2025Q2 | $0 | -$12.30 | -$8.99 | -$8.99 |
MBRX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -0.50 |
| 2026Q1 | -13.74% | -0.16 |
| 2025Q4 | 0% | 0.17 |
| 2025Q3 | 0% | -0.19 |
| 2025Q2 | 0% | -0.15 |
MBRX
Price: $0.26
52 week price:
Earnings Per Share: -16.16 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 14187
Ebitda: -2.9 millionMarket Capitalization: 2.6 million